Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Visudyne (verteporfin) Injection, 15 mg, QLT, NDA 21-119/S005 11/25/02 12/9/02 11/26/02 Visudyne (verteporfin) Injection, 15 mg, QLT, NDA 21-119/S004 5/29/02 6/3/02 5/31/02 Visudyne (verteporfin) Injection, 15 mg, QLT, NDA 21-119/S003 4/30/02 5/2/02 5/1/02 Visudyne (verteporfin) Injection, 15 mg, QLT, NDA 21-119/S001 8/22/01 11/6/01 11/6/01 12/12/01 Visudyne (verteporfin) Injection, 15 mg, QLT Photo Therapeutics NDA 21-119 4/12/00 4/17/00 4/17/00 12/11/01 Visudyne Indications: for the treatment of age-related macular degeneration in patients with predominantly classic subfoveal choroidal neovascularization. Visudyne (verteporfin) Injection, QLT, Inc. | Visudyne (verteporfin for injection), QLT Inc., Labeling Revision | Visudyne (verteporfin) Injection, QLT Inc., Labeling Revision | Visudyne (verteporfin) Injection, QLT, Inc., Efficacy Supplement with Clinical Data to Support View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com